Linda T. Joosten

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Coumarin or DOAC in frail elderly patients with atrial fibrillation?

Coumarin or DOAC in frail elderly patients with atrial fibrillation?

Journal: Nederlands tijdschrift voor geneeskunde

Published: March 25, 2024

Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.

Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.

Journal: Circulation

Published: August 27, 2023

Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis.

Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis.

Journal: Open heart

Published: November 04, 2022

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community.

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: January 13, 2022

Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients.

Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients.

Journal: International journal of cardiology. Heart & vasculature

Published: December 17, 2021

Cardiovascular vulnerability predicts hospitalisation in primary care clinically suspected and confirmed COVID-19 patients: A model development and validation study.

Cardiovascular vulnerability predicts hospitalisation in primary care clinically suspected and confirmed COVID-19 patients: A model development and validation study.

Journal: PloS one

Published: October 01, 2021

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Journal: BMJ open

Published: January 01, 2020

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation.

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation.

Journal: Annals of internal medicine

Published: June 04, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026